Overview

A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking Methotrexate

Status:
Completed

Trial end date:
2017-10-25

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the efficacy, pharmacokinetics, pharmacodynamics and safety of ASP1707 in combination with MTX in postmenopausal female patients with RA.

Phase:

Phase 2

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Methotrexate